GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MARX Biotech Co 7731.TWO · TWD

N/A · Taipei Exchange · 🇹🇼 Taiwan

Compare

4.09

+1.49%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About MARX Biotech Co

Its shares trade on Taipei Exchange under the ticker 7731.TWO. It has been listed since 5 February 2024. In the fiscal year to 31 December 2025, it reported revenue of TWD 635.9m and net income of TWD 42.9m. At that date it held total assets of TWD 832.7m and shareholders' equity of TWD 359.4m.

MARX Biotech Co Ltd is a TW-based company operating in industry. The company is headquartered in Taipei, New Taipei. The company went IPO on 2024-02-05. MARX Biotech Co Ltd is a Taiwan-based retail company that develops with data-driven innovation strategies. The firm's main product types span health foods, skin care products, hair products, health products and cleaning products, and are sold on domestic brand official sales platforms, e-commerce platforms, chain and small and medium-sized cosmeceutical pharmacies, and overseas cross-border e-commerce channels. The firm mainly operates four major brands, including the high-end men's health brand TAIZAKU, the skin care and health care brand Inyouso, the sports and children's health care brand Phargoods, and the beauty care brand SnowIOU.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
5 Feb 2024

Leadership

Pay as last reported

  • Youzheng ZhengAssistant General Manager of Finance
  • Bingyan CaiDeputy General Manager

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company is headquartered in Taipei, Taiwan
  • Operates four major brands including TAIZAKU and Inyouso
  • Main product types span health foods, skin care, and hair products

Weaknesses

  • Sector and industry information are listed as N/A
  • Company is described as a retail company despite being biotech
  • No specific financial data provided for analysis

Opportunities

  • IPO on 2024-02-05 provides potential for capital growth
  • Sells products through domestic and overseas e-commerce channels
  • Operates across multiple product categories including health and beauty

Threats

  • Company description contradicts biotech sector with retail operations
  • Untrusted source description may contain inaccuracies
  • No financial data available to assess market position

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.